UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease ...

“Gene therapy for hemophilia A with the use of lentiviral vector-transduced autologous HSCs resulted in stable factor VIII expression, with factor VIII activity correlating to vector copy number in ...

New gene therapy for maple syrup urine disease shows promise in preventing deadly symptoms in cows and offers hope for patients.

A promising study out of the United Kingdom has partially restored the vision of multiple small children born legally blind.

The Phase 3 ARTEMIS trial (NCT06856577) is designed to evaluate the safety and efficacy of Ixo-vec in a randomized (1:1), double-masked, sham-controlled, two-arm study. The US-based trial is intended ...

Welcome to the BioLife Solutions Q4 2024 shareholder and analyst conference call. (Operator Instructions). As a reminder, today's call is being recorded. I would now like to turn the conference call ...

The latest freezer and incubator technology aims to better preserve sample integrity and enable more physiologically-relevant ...

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who ...

LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) reported 2024 financial and operational ...

Tenaya intends to use the net proceeds from the offering to fund the ongoing and planned development of its clinical and ...

When Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...

BOTHELL, Wash. - BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading provider of cell processing tools for the cell and gene therapy market, saw its shares jump 7.9% after reporting ...